EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The potential of artificial intelligence in clinical trials

Rahul Aggarwal, Deepak L. Bhatt

European Journal of Clinical Investigation · 2026-03 · 56 (3)

DOI: 10.1111/eci.70182 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Clinical trials are an important part of evidence generation in medicine but remain burdened by escalating costs, inefficiencies and manual processes. Artificial intelligence (AI) has emerged as a promising approach to address these limitations by improving efficiency across the trial lifecycle. Methods In this review, we examine emerging applications of AI across the clinical trial lifecycle. We highlight key examples demonstrating feasibility and potential impact. Results AI‐based approaches show promise in optimizing trial design, improving recruitment, streamlining conduct and enhancing data interpretation. Despite the potential of AI in trials, challenges persist, including data quality, regulatory and privacy concerns, as well as infrastructure issues. Ethical use will require strong governance frameworks emphasizing transparency and human oversight. The success of these technologies will depend on their continuous validation and monitoring of these technologies. Conclusions With appropriate validation, monitoring and governance, AI could enable a more efficient, cost‐saving and effective clinical trial landscape that accelerates discovery.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →